<?xml version="1.0" encoding="UTF-8"?>
<p>Analysis were conducted from both payer and societal perspective. The payer perspective considered the costs assumed by healthcare system [
 <xref rid="pone.0233526.ref051" ref-type="bibr">51</xref>, 
 <xref rid="pone.0233526.ref060" ref-type="bibr">60</xref>]. In Spain there is a Public Healthcare System which covers all the health services included in the model but antiviral drugs indicated for influenza. Societal perspective included also the costs of antiviral drugs and indirect cost due to productivity losses [
 <xref rid="pone.0233526.ref051" ref-type="bibr">51</xref>, 
 <xref rid="pone.0233526.ref060" ref-type="bibr">60</xref>].
</p>
